Vascular endothelial growth factor in bipolar depression: A potential biomarker for diagnosis and treatment outcome prediction
Authors:
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 284, 112781
Abstract
No abstract availableKeywords
Funding Information
- Stanley Medical Research Institute
This publication has 40 references indexed in Scilit:
- Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapyActa Psychiatrica Scandinavica, 2013
- VEGF and depression: A comprehensive assessment of clinical dataJournal of Psychiatric Research, 2013
- Peripheral vascular endothelial growth factor level is associated with antidepressant treatment response: Results of a preliminary studyJournal of Affective Disorders, 2013
- Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attemptersTranslational Psychiatry, 2012
- Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude miceActa Neurochirurgica, 2012
- Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic featuresTherapeutic Advances in Psychopharmacology, 2012
- Role of vascular endothelial growth factor in adult hippocampal neurogenesis: Implications for the pathophysiology and treatment of depressionBehavioural Brain Research, 2012
- The Maudsley Staging Method for Treatment-Resistant DepressionThe Journal of Clinical Psychiatry, 2009
- Vascular niche for adult hippocampal neurogenesisJournal of Comparative Neurology, 2000
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989